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On the Ambiguity of 1,3,2-Benzodiazaboroles as Donor/Acceptor 
Functionalities in Luminescent Molecules 
 
Lothar Weber*[a], Johannes Halama[a], Kenny Hanke[a], Lena Böhling[a], Andreas 
Brockhinke*[a], Hans-Georg Stammler[a], Beate Neumann[a] and Mark A. Fox[b] 
 
Keywords: Boron / Diazaboroles / Perfluoroaryls / Photophysics 
 
Summary: 
A series of 1,3-bis(perfluoroaryl)-2-(hetero)aryl-1,3,2-benzodiazaboroles, 1,3-FAr2-2-Ar-1,3-
2-N2BC6H4 (Ar = Ph, FAr = C6F5 5; Ar = Ph, FAr = 4-C5F4N 6; Ar = Ph, FAr = 4-NCC6F4 7;  
Ar = 2-C4H3S, FAr = C6F5 8; Ar = 2-C4H3S, FAr = 4-C5F4N 9; Ar = 2-C4H3S, FAr = 4-NCC6F4 
10), were synthesised by cyclocondensation of the adducts PhBBr2⋅PPh3 or 2-thienyl 
BBr2⋅PPh3 with N,N´-bis(perfluoroaryl)-o-phenylenediamines in the presence of 2,2,6,6-
tetramethylpiperidine. Similar treatments of the PPh3 adducts of 4-(1´,3´-diethyl-1´,3´,2´-
benzodiazaborolyl)-phenyldibromoborane with the corresponding diamines gave rise to the 
push-pull compounds, C6H4(NEt)2B-1,4-C6H4-B(NFAr)2C6H4 (FAr = C6F5 11; 4-C5F4N 12) 
and C6H4(NEt)2B-2,5-C4H2S-B(NFAr)2C6H4 (FAr = C6F5 13; 4-C5F4N 14). The X-ray 
structures of 8, 11, 12 and 13 were determined. Electronic structure calculations reveal that 
the LUMOs are located at the perfluoroaryl groups in 5-14 thus the fluorinated 
benzodiazaborolyl groups are considered as electron-withdrawing moieties. These moieties 
differ from alkylated benzodiazaborolyl groups which are regarded as donors. The emission 
spectra for 5-14 show charge transfer bands with significant solvatochromism and large 
Stokes shifts (6100-12500 cm-1 in cyclohexane and 8900-15900 cm-1 in CH2Cl2). The 
emissions of the benzodiazaboroles, 5-10, arise from a different charge transfer (CT) process 
to the local charge transfer (LCT) process typically found in many fluorescent 
benzodiazaboroles. This novel remote charge transfer (RCT) process involving the 
perfluoroaryl groups is supported by CAM-B3LYP computations. The push-pull systems 11-
14 here give fluorescent emissions with moderate to high fluorescence quantum yields (65-
97%) that arise from the usual LCT process only.  
 
[a] Fakultät für Chemie der Universität Bielefeld,  
33615 Bielefeld, Germany 
Email: lothar.weber@uni-bielefeld.de, andreas.brockhinke@uni-bielefeld.de 
[b] Department of Chemistry, Durham University, South Road, Durham, DH1 3LE, UK 
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Electronic supplementary information (ESI) available: Lippert-Mataga analyses on 11-14, 
table comparing experimental and computed geometrical parameters for 11-13, cartesian 
coordinates for optimised geometries of 5, 11 and 20 and figures of MOs involved in the 
transitions of parent benzodiazaborole and model of the push pull system 22.  
 
Introduction: 
 
The chemistry of fluorescent organoboranes for potential application in electrooptical 
devices has attracted considerable interest. The most prominent three-coordinate boron 
substituent in these systems is the dimesitylboryl group (BMes2, Mes = 2,4,6-Me3C6H2) 
which functions as a π-electron acceptor due its vacant p-orbital at the boron centre.1 These 
compounds can display sizable second and third-order nonlinear optical (NLO) 
properties, 2 wherein the BMes2 acceptor strength is usually somewhere between that 
of NO2 and CN. They can also exhibit large two-photon absorption (TPA) cross-
sections and strong two-photon excited fluorescence (TPEF). 3 Such electron 
deficient compounds have low LUMO energies and have thus been shown to be 
efficient electron-transporting and/or emitting layers in organic light emitting diodes 
(OLEDs). 4 Compounds with BMes2 groups are often strongly colored and/or 
luminescent,5 and thus have potential for use as colorimetric or luminescent sensors 
for anions, particularly fluoride ions. 6 Conjugated molecules with boryl side groups 
have recently been shown to display very large Stokes shifts and high quantum 
yields both in solution and the solid state, properties which were attributed to the lack 
of close packing caused by the bulky mesityl groups. 7 Besides those with BMes2 
groups, optically interesting materials based on three-coordinate boron compounds 
have been reported recently including vinyleneboranes,8 diboraanthracenes,9 
borataanthracene anions,10 boracyclophanes,11 fluoreneboranes12 and 
aminoboranes.13 
 
In the past decade, the chemistry of 1,3,2-diazaboroles rapidly developed14-16 and 
some of these three-coordinate boron compounds are strongly luminescent.17-24 
Calculations on 2-arylethynyl-1,3-diethyl-1,3,2-benzodiazaboroles disclosed that the 
diazaborolyl unit did not function as a π-acceptor as anticipated, but instead behaved as a π-
donor substituent.19 It was experimentally confirmed that the π-donor capacity of the 
1,3-diethyl-1,3,2-benzodiazaborolyl group towards the BMes2-acceptor is between those of 
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3 
methoxy- and dimethylamino-groups.20 Benzodiazaboroles are also efficient donors when 
linked to the carbon atoms of carborane clusters.25,26  
 
In a recent paper, we reported on a series of carbazolylphenyl- and carbazolylthienyl- 
derivatives of benzodiazaboroles, 1-4, (Chart 1) where both N-atoms were substituted by 
electron-withdrawing pentafluorophenyl or tetrafluoropyridyl groups.27 Here, the 
benzodiazaboroles served as π-acceptors towards the π-donating N-carbazolyl unit. These 
compounds are luminescent with Stokes shifts between 1200 and 5000 cm-1 in cyclohexane 
and between 4800 and 6300 cm-1 in dichloromethane solutions. To understand the interaction 
of the fluoroarylated diazaborolyl units with phenyl- or thienyl groups, the parent derivatives, 
5-10, were targeted. The next logical step in the quest for novel push-pull molecules with 
tuneable photophysical properties was the construction of π-conducting scaffolds, 11-14, with 
both the novel electron-withdrawing fluoroaryl-functionalised benzodiazaborolyl groups and 
the familiar 1,3-diethyl-1,3,2-benzodiazaborolyl donor, as terminal substituents. 
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Chart 1. Fluoroaryl benzodiazaboroles 1-14 discussed in this study. 
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Results and Discussion 
 
The reported synthetic method leading to the diamine precursors, N,N´-bis(perfluoroaryl)-
ortho-phenylenediamines 15 and 16, was also applied here in the synthesis of the new 
diamine 17 from pentafluorobenzonitrile and lithiated ortho-phenylenediamine (Scheme 1).27  
These diamines were reacted with appropriate aryldibromoborane-triphenylphosphine adducts 
to generate the fluoroaryl-functionalised benzodiazaboroles, 1-10 here and elsewhere.27  
 
SiMe3
i) BBr3
CH2Cl2
ii) PPh3
HN
HN
BBr2
PPh3
F
F
F
F
F
F
F
F
F
F
HN
HN
N
N F
F
F
F
F
FF
F
HN
HN
F
F
CN
F
F
F
F
CN
F
F
15 16 17
15-17
5-7
SiMe3
S S
i) BBr3
CH2Cl2
ii) PPh3
BBr2
PPh3
15-17
8-10
2 TMP
toluene, 100°C
2 TMP
toluene, 100°C  
 
Scheme 1. Syntheses of fluorinated benzodiazaboroles 5-10. 
 
Aryldibromoboranes were produced by the treatment of trimethylsilylaryls with boron 
tribromide and combined with an excess of triphenylphosphine in dichloromethane to afford 
the corresponding adducts. These mixtures were subsequently freed from solvent in vacuo to 
give colourless solid residues. Toluene solutions of the adducts were reacted with 
phenylenediamines 15-17 in the presence of 2,2,6,6-tetramethylpiperidine (TMP) at 100 °C. 
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Under these conditions, the cyclocondensations were completed in 24-60 h. After removal of 
the piperidinium salts, the filtrates were evaporated to dryness. Sublimation at ca. 100°C was 
applied to remove excess PPh3 from 5, 6, 8 and 9. The crude products were crystallised from 
n-hexane (5, 9), toluene (6) or n-hexane/CH2Cl2 mixtures (8) to give colourless crystals in 
55-69% yields. In the case of crude compounds 7 and 10, featuring nitrile substituents, 
purification was effected by crystallisation from n-hexane (7) or a n-hexane/CH2Cl2 2:1 
mixture (10) to give yellow crystals in 14 and 36% yield respectively. 
 
In contrast to other non-fluorinated 2-aryl-1,3-bis(alkyl/aryl)benzodiazaboroles compounds  
5-10 are not affected by contact with air and moisture, and thus may be stored in air for 
months. The pentafluorophenyl derivatives 5 and 8 can be worked up in the presence of water 
whereas compounds 6, 7, 9 and 10 are hydrolysed to phenylene diamines. Diazaboroles 5, 6, 8 
and 9 are well soluble in the common aprotic organic solvents, and may be recrystallised from 
alkanes at low temperatures. Derivatives 7 and 10 are poorly soluble in alkanes.  
 
The reaction of freshly prepared 4-trimethylsilylphenyllithium with an equimolar amount of 
2-bromo-1,3-diethyl-1,3,2-benzodiazaborole28 in diethyl ether in the temperature range 
between -78 and 20°C led to the formation of 1-diazaborolyl-4-trimethylsilyl benzene 18 as 
colourless needles in 50% yield (Scheme 2). 
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19
BBr3, CH2Cl2
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PPh3
CH2Cl2
2h
PPh3
2 TMP
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SiMe3Li
B
N
N
Et
Br
Et
-78°C to r.t.
Et2O
SiMe3B
N
N
Et
Et
BBr3, CH2Cl2
r.t., 16h
BBr2B
N
N
Et
Et
PPh3
CH2Cl2
2h
BBr2B
N
N
Et
Et
PPh3
2 TMP
toluene, 100°C
15, 16
11, 12
18
 
 
Scheme 2. Syntheses of push-pull systems, 11-14. 
 
The solution of 18 in CH2Cl2 was treated at room temperature with 1 equiv. of boron 
tribromide over a period of 16 h and then combined with 1 equiv. of triphenylphosphine. The 
obtained adduct was allowed to react with the ortho-phenylenediamine derivatives 15 or 16 in 
hot toluene (100°C) in the presence of 2 equiv. of 2,2,6,6-tetramethylpiperidine (TMP) to 
afford products 11 and 12 as colourless solids in 32% and 23% yield respectively.  
 
Similar protocols were applied to the preparation of the thiophene-2,5-diyl-bridged 
benzodiazaboroles 13 and 14 (Scheme 3). Thus, ortho-lithiated 2-trimethylsilylthiophene was 
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8 
coupled with 1 equiv. of the bromoborole in diethyl ether at 20°C to give 2-thienyldiazaborole 
19 as a pale yellow oil after distillation (yield 81%). The reaction of 19 with boron tribromide 
was completed after 1 h, and the product was subsequently converted into its 
triphenylphosphine adduct. Base-assisted cyclocondensation of the adduct with phenylene 
diamines 15 and 16 gave rise to the formation of colourless solids 13 and 14, in 46% and 21% 
yield, respectively. 
 
Unlike 5-10, compounds 11-14 are air and moisture sensitive. Under an argon atmosphere 
they can be stored for months without decomposition. The pentafluorophenyl derivatives, 11 
and 13, are well soluble in the common aprotic organic solvents, whereas the 
tetrafluoropyridyl functionalised systems 12 and 14 are poorly soluble in alkanes. 
 
To compare with the fluorinated derivative 5, the non-fluorinated analogue 20 was 
made in 80% yield using N,N´-diphenyl-ortho-phenylenediamine as the diamine 
precursor (Scheme 3). 
 
HN
HN
CaH2
toluene N
B
N
BBr2 +
20  
Scheme 3. Synthesis of 20. 
 
The 11B{1H} NMR spectra of 5-7 show singlets at δ = 30.4-30.9 ppm, which in comparison to 
derivative 20 (δ = 28.3 ppm) are slightly deshielded reflecting the electron-withdrawing 
character of the heterocycle. Similarly, the 11B{1H} NMR spectra of 8-10 (δ = 27.4-28.5 ppm) 
are downfield shifted with respect to 19 (δ = 26.7 ppm). The 11B{1H} NMR spectra of the 1,4-
phenylene-bridged products 11 and 12 are characterised by broad singlets at δ = 29.3 and 
28.7 ppm, respectively. The 2,5-thiophene-bridged derivatives 13 and 14 show broad 
resonances at δ = 26.2 and 26.4 ppm, respectively. Thus, the 11B NMR spectra of the novel 
compounds are well comparable with other 2-phenyl- or 2-thienyl-1,3,2-benzodiazaboroles 
regardless of the substituents at the ring nitrogen atoms.20-23  
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X-ray crystallography 
Single crystals of 8 were grown from a 5:1 mixture of n-hexane and CH2Cl2 at 4°C 
(Figure 1). The compound crystallised as meroedric twins in the orthorhombic space group 
P212121. Due to the poor quality of the crystals and disordering of the thiophene rings, a 
detailed discussion of the bonding parameters is meaningless. Here it should be mentioned, 
however, that the thiophene ring and the BN heterocycle are close to coplanar (φ = 11.9°), 
whereas the C6F5-rings and the benzodiazaborole core enclose interplanar angles of 69.1 and 
69.3°. For the related compound 3, the angle φ between the central thiophene ring and the 
diazaborole plane was determined to 10.1°, whereas the C6F5 rings and the BN heterocycle 
enclose interplanar angles of 65.2 and 87.6°.27 
 
Figure 1. Molecular structure of 8.  
 
Molecular structures were determined for the two phenylene-bridged 
bis(benzodiazaboroles) 11 and 12 as well as for the thiophene-2,5-diyl derivative 13 (Figure 
2). Single crystals of 11 and 13 were grown from n-hexane whereas crystallisation of 12 was 
achieved from a 10:1 mixture of n-hexane and dichloromethane at -20°C. Derivatives 11 and 
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10 
13 featuring pentafluorophenyl substituents crystallise in the triclinic space group P1, whereas 
the monoclinic space group P21 was determined for the tetrafluoropyridyl derivative 12. The 
asymmetric units of 12 and 13 contain two independent molecules with virtually identical 
bond lengths and endocyclic bond angles.  
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Figure 2. Molecular structures of 11 (top), 12 (middle) and 13 (bottom). Hydrogen atoms are 
omitted for clarity. 
 
The bond lengths within both benzodiazaborolyl parts of the molecules in 11-13 are 
unexceptional with B-N, N-Cring, and C-C bonds of 1.44, 1.40 and 1.40 Å. As expected the 
exocyclic bonds N(1)-C(7) and N(2)-C(9) [ca. 1.46  Å] are significantly longer as compared 
with bonds N(3)-C(23) and N(4)-C(28) [ca. 1.40  Å] in 11 and 12 or N(3)-C(21) and N(4)-
C(27) [ca. 1.41 Å] in 13 to the differing hybridisation at the carbon atoms.  
Significant differences are found for the C-B bond lengths and the mutual orientations 
of the three ring systems as well as for the fluoroaryl substituents at the nitrogen atoms in 11-
13 (Figure 2). These parameters, summarised in Table 1, are of particular interest as a better 
overlap between the π-orbitals on boron and on the carbon atom attached to boron would 
occur if the arene moiety and the diazaborolyl functions are coplanar. The coplanarity 
between thiophene and the B/N heterocycle is more favourable (4.9-45.8°, av. 24.6°) in 13 
than for the diazaborole-benzene combination (41.4-45.3°, av. 43.3°) in 11 and 12 in the solid 
state as found in related systems elsewhere.20,21,23 The B-C bond lengths involving the 
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12 
alkylated heterocycle are longer than those involving the fluoroarylated benzodiazaborolyl 
groups which may be attributed to the electron-withdrawing character of the aryl groups as 
observed in similar systems.25,26 
It is noted that the para-phenylene ring in compound 11 contains two C-C bonds at 
1.386(1) and 1.388(1) Å where the C atoms are unsubstituted and four C-C bonds at 1.401(1)-
1.404(1) Å indicating a small degree of quinoid character. This degree of quinoid character is 
also found in the closely related structure of 11 with ethyl groups in place of fluoroaryl 
groups.21 However, in derivative 12 changes in the C-C bond lengths in the bridge are not 
significant within 3 esds.  
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Table 1. Selected geometric parameters of 11-13. Two independent molecules are present in the crystal structures of 12 and 13. Et2BDB = 1,3-
diethyl-1,3,2-benzodiazaborolyl group, FAr2BDB = 1,3-difluoroaryl-1,3,2-benzodiazaborolyl group. 
 11 12A 12B 13A 13B 
B-C bond length      
At Et2BDB group 1.565(1) Å 1.556(2) Å 1.553(2) Å 1.548(2) Å 1.551(2) Å 
At FAr2BDB group 1.551(1) Å 1.542(2) Å 1.537(2) Å 1.537(2) Å 1.540(2) Å 
Ring orientation       
Et2BDB – bridge N(1)-B(1)-C(11)-C(12)  
-45.3(1)° 
N(1)-B(1)-C(11)-C(12) 
44.1(2)° 
N(7)-B(3)-C(43)-C(44)  
-42.5(2)° 
N(1)-B(1)-C(11)-S(1) 
26.3(2)° 
N(5)-B(3)-C(43)-S(2) 
-45.8(2)° 
FAr2BDB – bridge N(3)-B(2)-C(14)-C(13) 
43.5(1)° 
N(3)-B(2)-C(14)-C(13) 
-41.4(2)° 
N(9)-B(4)-C(46)-C(45) 
42.9(2)° 
N(3)-B(2)-C(14)-S(1) 
21.1(2)° 
N(7)-B(4)-C(46)-S(2) 
4.9(2)° 
FAr-BDB B(2)-N(3)-C(23)-C(24) 
56.0(1)° 
B(2)-N(4)-C(29)-C(34) 
56.1(1)° 
B(2)-N(3)-C(23)-C(24) 
60.1(2)°  
B(2)-N(4)-C(28)-C(32) 
54.4(2)° 
B(4)-N(9)-C(55)-C(56) 
57.6(2)°  
B(4)-N(10)-C(60)-C(64) 
57.2(2)° 
B(2)-N(3)-C(21)-C(22) 
67.9(2)°  
B(2)-N(4)-C(27)-C(32) 
-69.0(2)° 
B(4)-N(7)-C(53)-C(54) 
58.2(2)°  
 B(4)-N(8)-C(59)-C(64) 
-60.5(2)° 
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Photophysics  
 
Photophysical data for compounds 1-14 and 20 in cyclohexane and CH2Cl2 solutions are 
listed in Table 2. Absorption and emission spectra are shown in Figures S1-3. As no 
emissions from solids of 1-14 under UV radiation were visible to the naked eye, no 
solid-state photophysical measurements were carried out. The absorption maxima for 
the reported27 compounds 1-4 containing the carbazolyl groups are at λmax = 340-344 nm 
whereas for compounds 5-12 and 20 they occur at λmax = 271-295 nm with little 
solvatochromism. While the lowest energy bands in 1-4 arise from π > π* transitions 
involving the π-bridge and carbazolyl groups,27 the π > π* transitions for compounds 5-12 and 
20 are likely to involve the benzodiazaborolyl groups. The absorption maxima for the 
thienylene ‘push-pull’ systems 13 and 14 are at 322-330 nm suggesting that the thiophene unit 
contributes significantly to the π > π* transitions.  
Emission maxima of the new compounds 5-12 showed very large Stokes shifts of 
between 6100 and 15900 cm-1 in contrast to the carbazolyl boroles 1-4 with values between 
1200 and 6100 cm-1. A large Stokes shift indicates that the solvated species goes through a 
significant geometry rearrangement under excitation.  
Many known organic π-systems containing 1,3-diethyl- and 1,3-diphenyl-1,3,2-
benzodiazaborolyl groups have Stokes shifts in the region of 5000-10000 cm-1 such as the 
non-fluorinated analogue 20 here at 5200-6400 cm-1 and high quantum yields.18-24 Such 
emissions from these reported systems arise from the S0 < S1 transitions involving the 
π*(organic π-system) and π(benzodiazaborolyl) orbitals (vide infra). In 20, the π*(organic π-
system) orbital would be at the phenyl group attached to the boron atom (vide infra). These 
emissions are considered to be charge transfer (CT) due to evidence of significant 
solvatochromism as reflected in the solvatochromic shifts (Table 2). However, the boron atom 
of the diazaborolyl unit is involved in both orbitals according to computations (vide infra) 
so there is a degree of local excitation (LE) involved which may explain the remarkable 
fluorescence properties of benzodiazaborolyl groups in organic π-systems.18-24  
As compounds 5 and 20 differ only in the fluorines instead of hydrogens at the phenyl 
groups attached to the nitrogens of the benzodiazaborole moiety, it is logical to compare their 
photophysical data. Compound 20 has a Stokes shift of 5200 cm-1 and a quantum yield of 
41% whereas compound 5 has the corresponding values of 10600 cm-1 and 2% respectively. 
In addition, the emission band for compound 5 has a more significant solvatochromic 
shift of 4300 cm-1 on going from cyclohexane to dichloromethane compared to 20 
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with a solvatochromic shift of 1200 cm-1. Thus, compounds with 1,3-difluoroaryl-1,3,2-
benzodiazaborolyl groups have more significant excited state geometry rearrangements than 
compounds with non-fluorinated benzodiazaborolyl groups suggesting a different charge 
transfer (CT) process. This process involves the fluorinated aryl groups and, since the 
fluorinated aryl orbitals (vide infra) involved in this process do not have contributions from 
the boron atom in the benzodiazaborolyl unit, are considered to be genuine charge transfer.  
To distinguish these two CT processes on the basis of the Stokes shifts, the 
transition involved in the emission of 20 is denoted local charge transfer (LCT) 
whereas the transition in the emission of 5 is remote charge transfer (RCT).  If this 
assumption is applied to compounds 6-10 then all emissions with large Stokes shifts 
in cyclohexane or dichloromethane are RCT except for emissions with smaller 
Stokes shifts of compounds 8 and 9 in cyclohexane which are LCT.(Table 2) These 
CT assignments are supported by the larger solvatochromic shifts found for RCT. 
The emission spectrum in dichloromethane for compound 8 contains two distinct 
bands at 362 nm and 503 nm which are assigned LCT and RCT respectively. The 
dual emission25,26,29 in 8 has lifetimes of ca 0.2 ns at 362 nm and 1.05 ns at 503 nm 
which shows that two independent excited states are formed. 
 The fluorescence quantum yields, ΦF, for the compounds 1-14 clearly depend on the 
nature of the substituent at the boron atom of the fluorinated benzodiazaborole. Low ΦF 
values are observed with phenyl or thienyl groups (5-10 with ΦF up to 8%) and generally high 
ΦF values with the 2-(1,3-diethyl-1,3,2-benzodiazaborolyl)aryl groups (11-14 with ΦF up to 
97%).  
 The quantum yields differ considerably in the case of compounds with the 
tetrafluoropyridyl groups (2, 4, 12, 14) where the values are lower in dichloromethane 
than in cyclohexane. Non-radiative processes are thus dominant in more polar 
solvents where the excited states involve the tetrafluoropyridyl groups. By contrast, 
the effect of solvent on the quantum yields is not obvious for compounds containing 
the pentafluorophenyl and cyanotetrafluorophenyl groups. 
Lippert-Mataga analyses carried out on 11-14 with four different solvents reveal that 
the transition dipole moments ∆µ are 15.8 D for 11, 23.0 D for 13 and 18.3 D for 14 which 
support the charge transfer nature of their emissions.(Figures S4-S7, Tables S2-S5) Values 
of 14.8 – 19.7 D have been determined for similar benzodiazaboroles with LCT emissions.22 
The ∆µ value for 12 could not be determined as there is no linear fit in the Lippert-Mataga 
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plot for 12. It is possible that either LCT or RCT emission takes place in different solvents for 
12. 
The push-pull systems, 21 and 22 (Chart 2),20 which differ from 11-14 by virtue of 
the electron-withdrawing BMes2 group instead of the fluoroaryl diazaborolyl group, have 
similar emission data to 11-14. In cyclohexane solutions, the Stokes shifts are 8800 cm-1 and 
6070 cm-1 and the quantum yields are 90% and 99% for 11 and 21 respectively. Similarly, the 
thiophene analogues have values of 6300 cm-1 and 6210 cm-1 and 59% and 81% for 13 and 22 
respectively. It may be concluded here that the emissions of the push-pull systems 11-14 are 
LCT like for many other reported organic π-systems with benzodiazaborolyl groups.18-24  
 
 
Chart 2. Push-pull systems, 21 and 22. 
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Table 2. Photophysical data for the benzodiazaboroles 2-Ar-1,3-Ar2-BN2C6H4, 1-14 and 20. Cz = 4,7-tBu2-carbazolyl group; BDB = 1,3-Et2-
benzodiazaborolyl group. 
 2-Ar 
 
1/3-Ar 
 
Solvent 
 
λmax,Abs 
 [nm] 
ν~
max,Abs 
[cm-1]  
ε 
[Lmol-1cm-1] 
λmax,Em 
 [nm] 
ν~
max,Em 
[cm-1] 
Stokes shift 
[cm-1] 
Φfl 
[%] 
Solvatochromic shift 
[cm-1] 
1 CzC6H4 C6F5 c-C6H12 344 29100 17700 358 27900 1200 79  
   CH2Cl2 344 29100 10000 407 24600 4500 26 3300 
2 CzC6H4 4-C5F4N c-C6H12 344 29100 11600 377 26200 2900 47  
   CH2Cl2 344 29100 10400 414 23800 5300  2400 
3 CzC4H2S C6F5 c-C6H12 340 29400 15600 394 25400 4000 14  
   CH2Cl2 340 29400 12000 411 24300 5100 18 1100 
4 CzC4H2S 4-C5F4N c-C6H12 340 29400 11600 410 24400 5000 16  
   CH2Cl2 341 29300 15900 431 23200 6100 2 1100 
5 C6H5 C6F5 c-C6H12 283 35300 11350 405 24270 10600 3  
   CH2Cl2 283 35300 6960 489 20500 14900 <1 4300 
6 C6H5 4-C5F4N c-C6H12 275 36400 18420 419 23900 12500 1  
   CH2Cl2 271 36900 20400 477 21000 15900 <1 3400 
7 C6H5 4-NCC6F4 c-C6H12 287 34800 7800 417 24000 10800 3  
   CH2Cl2 281 35600 18370 472 21200 14400 5 3600 
8 C4H3S C6F5 c-C6H12 291 34400 10430 353 28300 6100 8  
   CH2Cl2 
 
292 
 
34200 
 
16340 
 
362 
503 
27600 
19900 
6600 
14300 
<1 
 
500 
8200 
9 C4H3S 4-C5F4N c-C6H12 281 35600 12260 363 27400 8100 1  
   CH2Cl2 280 35700 2130 464 21600 14100 <1 6000 
10 C4H3S 4-NCC6F4 c-C6H12 289 34600 7110 408 24500 10100 1  
   CH2Cl2 290 34500 24110 483 20700 13800 2 3700 
11 BDBC6H4 C6F5 c-C6H12 293 34100 15080 395 25300 8800 90  
   CH2Cl2 295 33900 22150 428 23400 11300 97 2500 
12 BDBC6H4 4-C5F4N c-C6H12 286 35000 26040 408 24500 10500 95  
   CH2Cl2 289 34600 21930 447 22400 12200 2 1700 
13 BDBC4H2S C6F5 c-C6H12 322 31100 18780 404 24800 6300 59  
   CH2Cl2 320 31300 21710 446 22400 8900 65 2600 
14 BDBC4H2S 4-C5F4N c-C6H12 330 30300 10030 418 23900 6400 78  
   CH2Cl2 325 30800 9990 464 21600 9200 46 2800 
20 C6H5 C6H5 c-C6H12 295 33900 6670 349 28700 5200 41  
   CH2Cl2 295 33900 6440 364 27500 6400 38 1200 
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Computations 
Ground state geometry optimisations of 5-14 and 20 were computed at the B3LYP/6-31G* 
level of theory. A very good agreement was found between the optimised S0 geometries and 
the X-ray data of 11-13 (Table S6). However, the relative orientations between the 
benzodiazaborolyl plane and the planes of the bridge and fluoroaryl groups are 
somewhat more twisted in the computed geometries than in the experimental 
geometries. It is not possible to rotate the fluoroaryl groups attached to the nitrogen atoms in 
the benzodiazaboroles about the N-C bond. Geometries where both the 
benzodiazaborole unit and one of the fluoroaryl groups are coplanar could not be 
located due to the obvious steric barriers between these moieties. The sterics can be 
visualised by adjusting the fluoroaryl group containing F1 for 8 in Figure 1 to be 
coplanar with the benzodiazaborole unit resulting in the F1 atom occupying the space 
where the H6 atom is. However, the aryl or thienyl group attached to the boron atom can be 
rotated about the B-C bond with estimated energy barriers of only 3.8 and 1.1 kcal mol-1 for 5 
and 8, respectively. 
 
Molecular Orbitals 
The frontier orbitals in the parent benzodiazaborole are the π and π* orbitals on the 1,3,2- 
N2BC6H4 system (Figure S8). When a π–organic substituent is attached to boron, the HOMO 
is generally on the benzodiazaborolyl group whereas the LUMO is typically on the π–system 
attached to boron with some boron atom character. A π–organic substituent at nitrogen would 
also result in a HOMO on the benzodiazaborolyl group and in a LUMO on the substituent 
itself. Thus, if two π–organic substituents are attached to N and B like the systems discussed 
in this study, the LUMO may be located at either the substituent at N or at B, whereas the 
HOMO would be located on the benzodiazaborolyl moiety.  
 
For the non-fluorinated system, 1,2,3-Ph3-1,3,2-N2BC6H4 20, the LUMO is at the phenyl 
group attached to B. For the fluorinated system, 1,3-(C6F5)2-2-Ph-1,3,2-N2BC6H4 5, however, 
the LUMO resides at the C6F5 group (Figure 7). The same picture exists for compounds 6-10 
where the LUMOs are also located on the aryl groups attached to the nitrogen atoms of the 
diazaborole. The molecules with a thiophene unit have considerable contributions from the 
thiophene in both frontier orbitals. Each push-pull system (11-14) has the HOMO located at 
the N,N-diethyl benzodiazaborolyl group and the LUMO at the aryl groups in the N,N-diaryl 
benzodiazaborolyl group. 
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Figure 7. Molecular orbitals in the optimised ground state (S0) geometries for 1,2,3-Ph3- 
1,3,2-N2BC6H4 20 (left column) and 1,3-(C6F5)2-2-Ph-1,3,2-N2BC6H4 5 (right column). The 
MO contribution ratio of the three groups, Ph (at B) : N2BC6H4 :  Ar (at N), are given. 
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TD-DFT computations 
 
The hybrid functional CAM-B3LYP is used to compute charge transfer transitions as it has 
the necessary physics to model charge contributions more correctly than the widely used 
B3LYP functional.20 The data summarised in Table 3 show very good agreement between the 
observed absorption maxima of the strong bands and the computed maxima with predicted 
strong bands. However, bands with lower oscillator strengths are predicted at lower 
energies for 6, 7, 9 and 10. These weak bands are from transitions from the 
fluorinated rings to the benzodiazaborole unit (i.e. RCT). While the predicted weak 
bands for the tetrafluoropyridyl compounds 6 and 9 are not observed due to the 
strong bands, the weak bands for the cyano compounds 7 and 10 are present as 
shoulder bands. Based on Gaussian deconvolution analyses, these bands are 314 
nm (7) and 318 nm (10) in cyclohexane and 316 nm (7) and 322 nm (10) in 
dichloromethane. This has implications in determining the Stokes shifts – a Stokes shift is 
generally regarded as the energy difference between the lowest energy absorption band (S0 > 
S1) and the highest energy emission band (S0 < S1). Nevertheless, using the computed S0 > S1 
absorption data and observed emission data, the Stokes shifts remain large with values 
between 4300 and 10600 cm-1. 
 
All the strong absorption bands for 5-14 and 20 are assigned as arising from π-
benzodiazaborolyl > π*-B-aryl transitions. As described earlier, they are defined as local 
charge transfers (LCTs), these are not strictly local π > π* or charge transfer (CT) transitions 
as both orbitals contain some boron atom character. Compounds with thiophene units have 
considerable thiophene character in both frontier orbitals and therefore have thiophene 
character in the important transitions.20 Transitions at lower energies are predicted for 
compounds 6, 7, 9 and 10 on going from the benzodiazaborolyl HOMO to the fluorinated aryl 
group LUMO and defined as remote charge transfers (RCTs). 
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Table 3. Comparison between observed and computed absorption data for the benzodiazaboroles, 5-14 and 20.  
 
 λmax, 
Abs. 
Obs.a 
[nm] 
λmax, 
Abs. 
Calc.b 
[nm] 
Osc. 
Str.c 
Calc. 
 
 
Transition 
Type 
 
S0 > S1 
Abs. 
Calc.d 
[nm] 
Osc. 
Str. 
Calc. 
 
 
Transition 
Type 
 
Observed 
Stokes shift 
[cm-1] 
Calculated 
Stokes shifte 
λmax [cm
-1] 
5 283 283 0.2206 HOMO > LUMO+2 
π-borolyl > π*-BPh 
   10600 10600 
6 275 283 0.1934 HOMO > LUMO+2 
π-borolyl > π*-BPh 
307 0.0236 HOMO > LUMO 
π-borolyl > π*- FAr 
12500 11500 
7 287 281 0.1778 mixed 
 
333 0.0369 HOMO > LUMO 
π-borolyl > π*- FAr 
10800 11600 
8 291 298 0.2941 HOMO > LUMO 
π-borolyl /Th > π*-BTh/FAr 
   6100 5200 
9 281 290 0.2730 HOMO > LUMO+2 
π-borolyl /Th > π*-BTh/FAr 
314 0.0293 HOMO > LUMO 
π-borolyl/Th > π*- FAr 
8100 6900 
10 289 293 0.2985 HOMO > LUMO+2 
π-borolyl /Th > π*-BTh/FAr 
337 0.0027 HOMO > LUMO 
π-borolyl > π*- FAr 
10100 9600 
11 293 306 0.6368 HOMO > LUMO+1 
π-Et2borolyl > π*-BC6H4B 
   8800 7400 
12 286 308 0.4535 HOMO > LUMO+2 
π-Et2borolyl > π*-BC6H4B 
   10500 8000 
13 322 335 0.7578 HOMO > LUMO 
π-Et2borolyl/Th > π*-BThB 
   6300 5100 
14 330 341 0.6116 HOMO > LUMO, 
HOMO > LUMO+2 
π-Et2borolyl/Th > π*-BThB/FAr 
   6400 5400 
20 295 295 0.2667 HOMO > LUMO 
π-borolyl > π*-BPh 
   5200 5200 
a in cyclohexane 
b maxima with highest oscillator strength. 
c oscillator strength. 
d for calculated S0 > S1 transitions that are not also maxima with highest oscillator strengths. 
e energy difference between computed absorption maxima and observed emission data. 
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Excited state calculations 
The parent benzodiazaborole where only local π > π* and π < π* transitions within the fused 
heterocycle are possible has a computed Stokes shift of 2000 cm-1 based on calculated 
transitions from its S0 and S1 optimised geometries (Figure S8). This value agrees well with 
the observed Stokes shift of ca 2000 cm-1 for the related alkyl derivative, 2-tBu-1,3-Et2-1,3,2-
N2BC6H4. 24,26 For the benzodiazaboroles 5-14 and 20 here, the Stokes shifts are in the region 
of 5200-13400 cm-1 as listed in Table 3. As the observed Stokes shifts are large, the S1 
excited state geometries must be significantly different to the S0 ground state geometries.  
 
Two distinct excited state optimised geometries were located for 5, 8 and 9 and are denoted 
LCT and RCT. The LCT geometry involves changes within the diazaborolyl and B-aryl 
groups as reported elsewhere,20 whereas the RCT geometry involves a highly distorted aryl 
group at N as shown in Figure 8 for 5. The Stokes shifts based on TD-DFT data from S0 and 
S1(RCT) are generally larger than those from S0 and LCT as shown in Table 4. 
 
 
Figure 8. Molecular orbitals involved in the emissions for the two distinct excited state 
geometries of 5, LCT and RCT with calculated values 
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From Table 4, a comparison between the observed emission data in cyclohexane solutions and 
the computed emission data indicates that RCT emissions take place for compounds 5, 6, 7 
and 10 and LCT emissions take place for the other systems. RCT emissions are likely to take 
place for compounds 8 and 9 in the more polar dichloromethane solutions as solvatochromic 
shifts of 8200 and 6000 cm-1 on going from cyclohexane to CH2Cl2 are too large for LCT 
emissions to take place in both solvents. Two emission bands are observed in CH2Cl2 for 8 
which may be assigned as LCT and RCT emissions for the high and low energy bands, 
respectively.  
 
For compounds 11-14, the calculated and observed emission maxima based on LCT are in 
good agreement (Table 4). The orbitals involved in the LCT emission for 11 are shown in 
Figure 9. They closely resemble the orbitals involved in the LCT emission of the related push-
pull system, 21 (Figure S9) reported previously.20 
 
 
Figure 9. Molecular orbitals involved in the emission for the excited state LCT geometry 
of 11. Emission and Stokes shift values are calculated. 
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Table 4. Comparison between observed and computed emission data for the benzodiazaboroles, 5-14 and 20. The optimised LCT and RCT excited 
state geometries are used to compute the emission data. 
 
 λmax, Em 
Obs, 
cyclohexane 
[nm] 
λmax, Em 
(LCT) 
Calc 
[nm] 
Stokes shifta 
(LCT) 
Calc 
[cm-1] 
S0 < S1 
Transition 
Typeb 
 
λmax, Em 
(RCT) 
Calc 
[nm] 
Stokes shifta 
(RCT) 
Calc 
[cm-1] 
S0 < S1 
Transition 
Typeb 
 
 
Emission 
Assignment, 
cyclohexane 
 
5 405 345 6100 π-borolyl < π*-BPh 461 13400 π-borolyl < π*- FAr RCT 
6 419 -c   486 12000 π-borolyl < π*- FAr RCT 
7 417 -c   484 9300 π-borolyl < π*- FAr RCT 
8 353 395 8300 π-borolyl/Th < π*-BTh 473 12500 π-borolyl/Th < π*- FAr LCT 
9 363 406 7200 π-borolyl/Th < π*-BTh 505 12000 π-borolyl/Th < π*- FAr LCT 
10 408 -c   511 10100 π-borolyl/Th < π*- FAr RCT 
11 395 395 7400 π-borolyl < π*-BC6H4B -
d   LCT 
12 408 418 8600 π-borolyl < π*-BC6H4B 487 11900 π-borolyl/Th < π*- 
FAr LCT 
13 404 436 7000 π-borolyl/Th < π*-BThB -d   LCT 
14 418 448 7000 π-borolyl/Th < π*-BThB -d   LCT 
20 349 372 7000 π-borolyl < π*-BPh -d   LCT 
 
a Energy difference between computed absorption maxima (Table 3) and computed emission data. 
b From molecular orbital calculations on the optimised excited state geometries where the LUMO is assumed to be the highest occupied spin orbital 
and the HOMO is assumed as the second highest occupied spin orbital. 
c Optimised LCT geometry could not be located. 
d Optimised RCT geometry could not be located. 
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Conclusions 
Ten new compounds, 5-14, containing the electron-withdrawing 
bis(perfluoroaryl)benzodiazaborolyl groups were synthesised to examine the influence of the 
fluorinated rings on the photophysical properties of benzodiazaboroles. The 
benzodiazaboroles 5-10 exhibit weak fluorescence emissions with pronounced Stokes shifts 
up to 15900 cm-1 which arise from charge transfer of the excited states involving the 
perfluoroaryl groups. This unusual CT process is supported by excited state geometries 
located computationally and differs from the emission process involving many highly 
fluorescent organic systems with benzodiazaborolyl groups.  The push-pull systems 11-14, 
containing fluorinated benzodiazaborolyl groups as acceptors and alkylated 
benzodiazaborolyl groups as donors, did not result in pure charge transfer emissions between 
the two groups. The photophysical and computational data for these push-pull systems 
resemble other push-pull benzodiazaboroles where the BMes2 group is used as the acceptor. 
Thus, the π-donor or π-acceptor character of a benzodiazaborole unit may easily be tailored 
by the choice of the substituents at the nitrogens of the heterocycle. 
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Experimental Section 
 
All manipulations were performed under an atmosphere of dry, oxygen-free argon by using 
Schlenk techniques. All solvents were dried by standard methods and freshly distilled prior to 
use. The compounds 1,2-(HN-4´-pyridyl)2C6H4,27 1,2-(HNPh)2C6H4,27 1,2-(HNC6F5)2C6H4,30 
1-Br-4-Me3Si-C6H4,31 2-Me3Si-C4H3S32 and 2-bromo-1,3-diethyl-1,3,2-benzodiazaborole28 
were prepared according to literature methods. Boron tribromide, 2,2,6,6-
tetramethylpiperidine, triphenylphosphine, n- and tert-butyllithium were purchased 
commercially.  
 
NMR spectra were recorded at room temperature in C6D6 or CDCl3 on a Bruker Avance III 
300 (1H: 300, 11B: 96, 13C: 75, 19F: 282 MHz) or a Bruker Avance III 500 spectrometer (1H: 
500, 11B: 160, 13C: 125, 19F: 470, 31P: 202 MHz) with SiMe4 (1H, 13C), BF3·OEt2 (11B), CFCl3 
(19F) and 85% H3PO4 (31P) as external standards. Some expected 13C peaks 
corresponding to the boron-bound carbon atoms were not detected above the noise 
level while some 13C peaks corresponding to carbon atoms of the FAr groups were 
obscured by other peaks in the same region. Mass spectra were obtained with a VG 
autospec sector field mass spectrometer (Micromass). In some cases, the C-mass 
fractions in the elemental analyses were too low, which may be rationalized by 
incomplete combustion of boron carbides formed in this process.  
 
2-Phenyl-1,3-bis(pentafluorophenyl)-1,3,2-benzodiazaborole (5) 
A sample of boron tribromide (0.526 g, 2.1 mmol) was added at 20°C to a solution of 
phenyltrimethylsilane (0.330 g, 2.2 mmol) in dichloromethane (30 mL). The mixture was 
stirred for 16 h before a solution of triphenylphosphine (0.655 g, 2.5 mmol) in 
dichloromethane (10 mL) was added. After 2 h of stirring at room temperature volatiles were 
removed in vacuo, and NMR spectra were taken from the colourless solid residue 
(δ11B (C6D6) = -4.7 (s), δ31P (C6D6) = -3.9 (s) ppm). This adduct and 
N,N´-bis(pentafluorophenyl)phenylenediamine 15 (0.924 g, 2.1 mmol) were dissolved in 
toluene (70 mL) and 2,2,6,6-tetramethylpiperidine was added (0.636 g, 4.5 mmol). The 
mixture was heated at 100°C for 24 h and then cooled to 20°C. It was filtered and the filtrate 
was evaporated to dryness. The residue was freed from triphenylphosphine by sublimation in 
vacuo at 90-100°C. The residue was crystallised from n-hexane to yield 0.640 g (1.16 mmol, 
55%) of 5.  
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1H NMR (C6D6): δ= 6.66 (m, 2H, CH=CHCH=CH), 7.00 (m, 3H, m, p-Ph-H), 7.05 (m, 2H, 
CH=CHCH=CH), 7.34 (m, 2H, o-Ph-H) ppm. 13C{1H} NMR (C6D6): δ=110.8 (s, 
CH=CHCH=CH), 122.3 (s, CH=CHCH=CH), 128.5, 130.5, 132.4 (3s, BC-CH-CH-CH), 
136.1 (s, N2C2), 138.0 (dm, 1JC,F=255 Hz, C6F5), 140.6 (dm, 1JC,F=255 Hz, C6F5), 144.2 (dm, 
1
JC,F=255 Hz, C6F5) ppm. 11B{1H} NMR (C6D6): δ= 30.7 (s) ppm. 19F{1H} NMR (C6D6): δ= -
161.3 (m, 4F, m-F), -154.3 (t, 1JF,F=22 Hz, 2F, p-F), -146.1 (m, 4F, o-F) ppm. MS/EI (m/z): 
526.1 (100%) [M+]. C24H9BF10N2 (526.14): calcd.: C: 54.79, H: 1.72, N: 5.32; found: C: 
54.62, H: 1.85, N: 5.23. 
 
2-Phenyl-1,3-bis(2´,3´,5´,6´-tetrafluoropyridyl)-1,3,2-benzodiazaborole (6) 
According to the protocol for 5 2.1 mmol of adduct PhBBr2⋅PPh3 was reacted with an 
equimolar amount of N,N´-bis(tetrafluoropyridyl)-ortho-phenylenediamine 16 (0.853 g) and 
4.5 mmol (0.636 g) of 2,2,6,6-tetramethylpiperidine in toluene at 100°C for 24 h. After 
filtration and evaporation of the filtrate to dryness triphenylphosphine was sublimed off at 
90°C in vacuo. The residue was crystallised from toluene at -20°C to give product 6 (0.710 g, 
69%).  
1H NMR (C6D6): δ= 6.52 (m, 2H, CH=CHCH=CH), 6.90 (t, 2H, 3JH,H=7.1 Hz, m-Ph-H), 6.99 
(m, 3H, CH=CHCH=CH and p-Ph-H), 7.10 (d, 2H, 3JH,H=7.0 Hz, o-Ph-H) ppm. 13C{1H} 
NMR (C6D6): δ= 111.2 (s, CH=CHCH=CH), 122.7 (s, CH=CHCH=CH), 128.5, 130.7, 131.9 
(3s, BC-CH-CH-CH), 134.4 (s, N2C2), 138.6 (dm, 1JC,F=263 Hz, C5F4N), 144.0 (dm, 
1
JC,F=245 Hz, C5F4N) ppm. 11B{1H} NMR (C6D6): δ= 30.4 (s) ppm. 19F{1H} NMR (C6D6): 
δ= -145.31 (m, 4F, o-F), -88.01 (m, 4F, m-F) ppm. MS/EI (m/z): 492.0 (100%) [M+], 472.0 
(10%) [M+ –HF]. HRMS-EI (C22H9BF8N4): calcd.: 492.07870; found: 492.07953. 
 
N,N´-ortho-Bis(2,3,5,6-tetrafluoro-4-cyanophenyl)-phenylenediamine (17) 
A chilled solution (-78°C) of n-butyllithium in n-hexane (116 mL, 186 mmol) was combined 
portionwise with hexamethyldisilazane (30.0 g, 186 mmol). The mixture was transferred into 
chilled (-78°C) dropping funnel and then added during 60-70 min to a cold (-78°C) solution 
of ortho-phenylenediamine (5.0 g, 46.0 mmol) in THF (150 mL). The dark violet reaction 
mixture was warmed to 0°C, and then re-cooled to -78°C before a sample of pentafluoro-
benzonitrile (17.8 mL, 92.2 mmol) was added. The mixture was warmed to ambient 
temperature within 16 h, and subsequently combined with water (80 mL) and THF (50 mL). 
The organic phase was separated and washed with brine (2x50 mL). The combined aqueous 
phases were extracted with THF (3x50 mL). Then the combined THF phases were dried with 
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Na2SO4 and filtered. The filtrate was evaporated to dryness. The brown solid reaction residue 
was suspended in toluene (250 mL). The obtained solid which contained the product was 
filtered off and dried. This extraction procedure was repeated three times. Purification of the 
crude product was effected by crystallisation from dichloromethane (350 mL). N,N´-ortho-
Bis(2,3,5,6-tetrafluoro-4-cyanophenyl)-phenylenediamine 17 was obtained as pale pink 
crystals (12.5 g, 27.5 mmol, 60%).1H NMR (CDCl3): δ= 6.08 (s, br, 2H, NH), 7.05 (m, 2H, 
CH=CHCH=CH), 7.23 (m, 2H, CH=CHCH=CH) ppm. 13C-{1H}-NMR (CD2Cl2): δ= 83.2 (m, 
C5F4CCN), 108.7 (s, C6F4CN) 122.4 (s, CH=CHCH=CH), 126.4 (s, CH=CHCH=CH), 132.9 
(s, N2C2), 138.6 (dm, 1JC,F = 246Hz, C6F4CN), 148.5 (dm, 1JC,F = 261Hz, C6F4CN) ppm. 
19F{1H}-NMR (CDCl3): δ= -150.6 (m, 4F, o-F), -133.1 (m, 4F, m-F) ppm. MS/EI (m/z): 
454.0 (100 %) [M+], 434.0 (52%) [M+ -HF].C20H6F8N4 (454.28): calcd.: C: 52.88, H: 1.33, N: 
12.33; found: C: 52.91, H: 2.70, N: 12.31. 
 
2-Phenyl-1,3-bis(2´,3´,5´,6´-tetrafluoro-4´-cyanophenyl)-1,3,2-benzodiazaborole (7) 
Analogously to the synthesis of 5 the adduct of PhBBr2⋅PPh3 (2.1 mmol) was reacted with 
2.1 mmol (0.954 g) of N,N´-ortho-bis(2,3,5,6-tetrafluoro-4-cyanophenyl)-phenylenediamine 
17 and 2,2,6,6-tetramethyl-piperidine (0.636 g, 4.5 mmol) in toluene at 100°C for 60 h. The 
solid residue from the filtrated reaction mixture was dissolved in a mixture of CH2Cl2 
(10 mL) and n-hexane (25 mL) and stored at -20°C, whereby PPh3 and unreacted 
ortho-phenylenediamine precipitated. This mixture was filtered and the filtrate was 
freed from solvent. The residue was dissolved in n-hexane and stored at -20°C for a few 
days. By this large yellow orange crystals of 7 (162 mg, 0.30 mmol, 14%) were obtained. 1H 
NMR (C6D6): δ= 6.63 (m, 2H, CH=CHCH=CH), 6.99 (m, 3H, m,p-Ph-H), 7.03 (m, 2H, 
CH=CHCH=CH), 7.22 (m, 2H, o-Ph-H) ppm. 13C-{1H} NMR (C6D6): δ=111.0 (s, 
CH=CHCH=CH), 122.7 (s, CH=CHCH=CH), 128.5, 130.7, 131.9, (3s, BC-CH-CH-CH), 
135.0 (s, N2C2), 143.2 (dm, 1JC,F=260 Hz, C6F4CN), 147.1 (dm, 1JC,F=264 Hz, C6F4CN) ppm. 
11B-{1H} NMR (C6D6): δ= 30.9 (s) ppm. 19F-{1H} NMR ( C6D6): δ= -142.7 (m, 4F, o-F), -
131.7 (m, 4F, m-F) ppm. MS/EI (m/z): 540.1 (100%) [M+], 520.1 (5%) [M+ -HF]. HRMS-EI 
(C26H9BF8N4): calcd.: 540.07870; found: 540.07957. 
 
2-Thienyl-1,3-bis(pentafluorophenyl)-1,3,2-benzodiazaborole (8) 
Following the same protocol, 2-trimethylsilylthiophene (0.343 g, 2.2 mmol) was reacted with 
0.526 g (2.1 mmol) of BBr3 in 30 mL of CH2Cl2 for 2 h. After the addition of PPh3 (0.655 g, 
2.5 mmol) the adduct was isolated from the solution (δ11B (C6D6) = -7.1 (s), δ31P (C6D6) = -
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4.5 (s) ppm) and dissolved in toluene (70 mL) together with N,N´-bis(pentafluorophenyl)-
ortho-phenylenediamine 15 (0.924 g, 2.1 mmol) and 0.636 g (4.5 mmol) of 2,2,6,6-
tetramethyl-piperidine. The mixture was heated at 100°C for 16 h, cooled to room 
temperature and filtered. After evaporation of the filtrate, the dry residue was first sublimed in 
vacuo at 90-100°C to remove the phosphine and crystallised from an n-hexane/CH2Cl2 
mixture (25/5 mL) at 4°C to afford compound 8 (0.750 g, 1.41 mmol, 67%) as colourless 
crystals. 1H NMR (C6D6): δ= 6.75 (m, 2H, CH=CHCH=CH), 6.81 (t, 3JH,H =4.1 Hz, 1H, 4-H-
thiophene), 7.09 (d, 3JH,H=4.0 Hz, 1H, 3-H-thiophene), 7.15 (m, 2H, CH=CHCH=CH), 7.64 
(d, 3JH,H=4.1 Hz ,1H, 5-H-thiophene) ppm. 13C{1H} NMR (C6D6): δ= 110.4 (s, 
CH=CHCH=CH), 122.1 (s, CH=CHCH=CH), 128.5, 131.9, 134.8 (3s, BCCHCHCHS), 136.1 
(s, N2C2), 138.0 (dm, 1JC,F=252 Hz, C6F5), 140.8 (dm, 1JC,F=255 Hz, C6F5), 144.5 (dm, 
1
JC,F=252 Hz, C6F5) ppm. 11B{1H} NMR (C6D6): δ= 27.8 (s) ppm. 19F{1H} NMR (C6D6): δ= -
160.9 (m, 4F, m-F), -153.8 (t, 1JF,F=22 Hz, 2F, p-F), -145.2 (m, 4F, o-F) ppm. MS/EI (m/z): 
531.9 (100%) [M+], 511.9 (6%) [M+ -HF]. C22H7BF10N2S (532.16): calcd.: C: 49.65, H: 1.33, 
N: 5.26; found: C: 48.88, H: 1.13, N: 5.15. 
 
2-Thienyl-1,3-bis(2´,3´,5´,6´-tetrafluoropyridyl)-1,3,2-benzodiazaborole (9) 
The adduct of 2-Br2B-C4H3S and PPh3 (1.084 g, 2.1 mmol), was prepared as described before 
and treated with 1 equiv. of N,N´-bis(tetrafluoropyridyl)-ortho-phenylenediamine 16 (0.853 g) 
and 0.636 g (4.5 mmol) of 2,2,6,6-tetramethylpiperidine in toluene at 100°C for 16 h. After an 
analogous work up the reaction residue was sublimed in vacuo at 90°C to remove PPh3 and 
then at 140°C, whereby product 9 separated as a colourless solid. The latter fraction was 
purified by crystallisation from n-hexane to yield 0.650 g of product (1.30 mmol, 62%). 1H 
NMR (CDCl3): δ= 6.94 (m, 2H, CH=CHCH=CH), 7.10 (d, 3JH,H=3.4 Hz, 1H, 3-H-thiophene), 
7.17 (t, 3JH,H=3.6 Hz, 1H, 4-H-thiophene), 7.24 (m, 2H, CH=CHCH=CH), 7.64 (d, 
3
JH,H=4.0 Hz, 1H, 5-H-thiophene) ppm. 13C{1H} NMR (CDCl3): δ= 110.9 (s, 
CH=CHCH=CH), 119.9 (s, CH=CHCH=CH), 128.9, 132.5, 135.3 (3s, BC-CH-CH-CH-S), 
134.7 (s, N2C2), 138.6 (dm, 1JC,F=265 Hz, C5F4N), 144.1 (dm, 1JC,F=248 Hz, C5F4N) ppm. 
11B{1H} NMR (CDCl3): δ= 27.4 (s) ppm. 19F{1H} NMR (CDCl3): δ= -144.3 (m, 4F, o-F), -
87.4 (m, 4F, m-F) ppm. MS/EI (m/z): 498.1 (100%) [M+], 478.1 (10%) [M+ -HF]. 
C20H7BF8N4S (498.16): calcd.: C: 48.22, H: 1.42, N: 11.25; found: C: 47.10, H: 1.55, N: 
10.80. 
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2-Thienyl-1,3-bis(2´,3´,5´,6´-tetrafluoro-4-cyanophenyl)-1,3,2-benzodiazaborole (10) 
By analogy to the protocol above the adduct from 2-Br2B-C4H3S and PPh3 (1.084 g, 
2.1 mmol) was treated with 1 equiv. of N,N´-ortho-bis(2,3,5,6-tetrafluoro-4-
cyanophenyl)phenylenediamine 17 (0.954 g) and 0.636 g (4.5 mmol) of 2,2,6,6-tetramethyl-
piperidine in 100 mL of toluene (100°C) for 60 h. The reaction mixture was freed from 
solvent by evaporation, and the solid residue was washed with n-hexane (2 x 50 mL). 
Crystallisation from a 2:1 mixture of n-hexane/CH2Cl2 at -30°C afforded 10 as yellow crystals 
(yield 0.412 g, 0.75 mmol, 36%). 1H NMR (C6D6): δ= 6.60 (m, 2H, CH=CHCH=CH), 6.69 (t, 
3
JH,H=4.3 Hz, 1H, 4-H-thiophene), 6.90 (d, 3JH,H=4.0 Hz, 1H, 3-H-thiophene), 6.97 (d, 
3
JH,H=4.3 Hz, 1H, 5-H-thiophene), 7.01 (m, 2H, CH=CHCH=CH) ppm. 13C{1H} NMR 
(C6D6): δ=110.8 (s, CH=CHCH=CH), 122.7 (s, CH=CHCH=CH), 128.5, 130.7, 131.9 (3s, 
BC-CH-CH-CH-S), 135.0 (s, N2C2),143.0 (dm, 1JC,F=260 Hz, C6F4CN), 147.4 (dm, 
1
JC,F=264 Hz, C6F4CN) ppm. 11B{1H} NMR (C6D6): δ= 28.5 (s) ppm. 19F{1H} NMR (C6D6): 
δ= -142.1 (m, 4F, o-F) -131.4 (m, 4F, m-F) ppm. MS/EI (m/z): 545.9 (100%) [M+], 525.9 
(7%) [M+ -HF]. HRMS-EI (C24H7BF8N4S): calcd.: 546.03512; found: 546.03462. 
 
 
1,3-Diethyl-2-(4´-trimethylsilyl-1´-phenyl)-1,3,2-benzodiazaborole (18) 
A chilled solution (-78°C) of 1-bromo-4-trimethylsilylbenzene (2.07 g, 9.03 mmol) in diethyl 
ether (50 mL) was dropwise combined with a n-pentane solution of tert-butyllithium (1.6 M, 
29 mL, 18.1 mmol). The solution was warmed to 0°C and then re-cooled to -78°C before 
solid 2-bromo-1,3-diethyl-1,3,2-benzodiazaborole (2.27 g, 9.00 mmol) was added. During 
16 h the mixture was allowed to reach room temperature. Solvent was removed in vacuo, and 
the residue was distilled (bath temperature 170°C 10-6 bar) to afford a colourless oil. The oil 
was completely dissolved in n-hexane. Storage of the solution at -20°C for two days 
furnished colourless crystals of 18 (1.45 g, 4.5 mmol, 50%). 1H NMR (C6D6): δ=0.26 (s, 
9H, SiMe3), 1.08 (t, 3JH,H =7.2 Hz, 6H, NCH2CH3), 3.57 (q, 3JH,H=7.2 Hz, 4H, NCH2CH3), 
7.01 (m, 2H, CH=CHCH=CH), 7.14 (m, 2H, CH=CHCH=CH), 7.60 (s, 4H, Ph-H) ppm. 
13C{1H} NMR (C6D6): δ=0.0 (s, Si(CH3)3), 17.4 (s, CH3CH2N), 38.8 (s, CH3CH2N), 110.5 (s, 
CH=CHCH=CH), 120.4 (s, CH=CHCH=CH), 134.2, 134.4 (2s, C-Ph), 138.7 (s, N2C2), 141.7 
(s, Si-C-Ph) ppm. 11B{1H} NMR (C6D6): δ= 29.3 (s) ppm. MS/EI (m/z): 322.2 (100%) [M+], 
307.2 (21%) [M+ -CH3], 233.1 (25%) [M+ -Et, -4CH3].C19H27BN2Si (322.33): calcd.: C: 
70.80, H: 8.44, N: 8.69; found: C: 70.09, H: 8.87, N: 8.56. 
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1-(1´,3´-Bis(pentafluorophenyl)-1,3,2-benzodiazaborolyl)-4-(1´´,3´´-diethyl-1´´,3´´,2´´-
benzodiazaborolyl)-benzene (11) 
A solution of 18 (0.644 g, 2.0 mmol) in CH2Cl2 (30 mL) was treated at 20°C with boron 
tribromide (0.501 g, 2.0 mmol). After a period of 16 h a solution of triphenylphosphine 
(0.577 g, 2.2 mmol) in CH2Cl2 (10 mL) was added. After 2 h of stirring volatile compounds 
were removed in vacuo and NMR spectra of the residue were recorded (δ11B (C6D6) = -4.3 
(s), δ31P (C6D6) = -4.0 (s) ppm). A slurry of the adduct in toluene (60 mL) was combined with 
N,N´-bis(pentafluorophenyl)phenylenediamine 15 (0.792 g, 1.8 mmol) and 2,2,6,6-
tetramethyl-piperidine (0.636 g, 4.5 mmol), and heated for 16 h at 100°C. The resulting 
mixture was evaporated to dryness and triphenylphosphine was removed by sublimation at 
90-100°C and 10-6 bar. The residue was stirred in n-hexane (40 mL) and the slurry was 
filtered. Storing of the filtrate at -20°C for a few days afforded product 11 (0.400 g, 
0.57 mmol, 32%) as colourless crystals. 1H NMR (C6D6): δ= 0.88 (t, 3JH,H =7.0 Hz, 6H, 
NCH2CH3), 3.36 (q, 3JH,H=7.0 Hz, 4H, NCH2CH3), 6.68 (m, 2H, CH=CHCH=CH-
BN2(C6F5)2), 6.90 (m, 2H, CH=CHCH=CH-BN2Et2), 7.07 (m, 4H, CH=CHCH=CH-
BN2(C6F5)2 and -BN2Et2), 7.47 (d, 3JH,H=8.0 Hz, 2H, Ph-H), 7.57 (d, 3JH,H=8.0 Hz, 2H, Ph-
H) ppm. 13C{1H} NMR (C6D6): δ=15.8 (s, CH3CH2N), 37.4 (s, CH3CH2N), 109.2 (s, 
CH=CHCH=CHBN2Et2), 110.7 (s, CH=CHCH=CH-BN2(C6F5)2), 119.1 (s, 
CH=CHCH=CHBN2Et2), 122.3 (s, CH=CHCH=CH-BN2(C6F5)2), 132.0, 133.6 (2s, Ph-CH) 
136.2, 137.1 (2s, N2C2), 137.9 (dm, 1JC,F=254 Hz, C6F5), 140.6 (dm, 1JC,F=255 Hz, C6F5), 
144.2 (dm, 1JC,F=251 Hz, C6F5) ppm. 11B{1H} NMR (C6D6): δ= 29.3 (s) ppm. 19F{1H} NMR 
(C6D6): δ= -161.3 (m, 4F, m-F) , -154.2 (t, 1JF,F=22 Hz, 2F, p-F), -146.1 (m, 4F, o-F) ppm. 
MS/EI (m/z): 698.2 (100%) [M+], 683.2 (29%) [M+ -CH3]. HRMS-EI (C34H22B2F10N4): 
calcd.:698.18654; found: 698.18756. 
 
1-(1´,3´-Bis(2´´,3´´,5´´,6´´-tetrafluoropyridyl)-1,3,2-benzodiazaborolyl)-4-(1´´´,3´´´-diethyl-
1´´´,3´´´,2´´´-benzodiazaborolyl)-benzene (12) 
Compound 18 (0.644 g, 2.0 mmol) was reacted with BBr3 (0.501, 2.0 mmol) and 
subsequently PPh3 (0.577 g, 2.2 mmol)was added to the dichloromethane mixture as described 
before in protocol for 11. The obtained dibromoboryl-triphenylphosphine adduct (1.376 g, 
2.0 mmol) was combined with N,N´-bis(tetrafluoropyridyl)-ortho-phenylenediamine 16 
(0.731 g, 1.8 mmol) and 2,2,6,6-tetramethylpiperidine (0.636 g, 4.5 mmol) were reacted in 
toluene at 100°C for 24 h. It was filtered, and the solid was crystallised from a mixture of n-
hexane/CH2Cl2 (40/4 mL) whereby colourless crystals of 12 were obtained (0.280 g, 
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0.42 mmol, 23%). 1H NMR (C6D6): δ= 0.93(t, 3JH,H =7.1 Hz, 6H, NCH2CH3), 3.37 (q, 
3
JH,H=7.1 Hz, 4H, NCH2CH3), 6.53 (m, 2H, CH=CHCH=CH-BN2(C5F4N)2), 6.93 (m, 2H, 
CH=CHCH=CH-BN2Et2), 7.00 (m, 2H, CH=CHCH=CH-BN2(C5F4N)2), 7.10 (m, 2H, 
CH=CHCH=CH-BN2Et2), 7.31 (d, 3JH,H=7.8 Hz, 2H, Ph-H), 7.38 (d, 3JH,H=7.8 Hz, 2H, Ph-
H) ppm. 13C{1H} NMR (C6D6): δ= 15.9 (s, NCH2CH3), 37.4 (s, NCH2CH3), 109.2 (s, 
CH=CHCH=CHBN2Et2), 111.3 (s, CH=CHCH=CH-BN2(C5F4N)2), 119.2 (s, 
CH=CHCH=CHBN2Et2), 122.9 (s, CH=CHCH=CH-BN2(C5F4N)2), 134.6, 137.1 (2s, Ph-CH), 
131.6, 133.6 (2s, N2C2), 138.8 (dm, 1JC,F=262 Hz, C5F4N), 144.0 (dm, 1JC,F=248 Hz, 
C5F4N) ppm. 11B{1H} NMR (C6D6): δ= 28.7 (s) ppm. 19F{1H} NMR (C6D6): δ= -87.9 (m, 4F, 
m-F), -145.1 (m, 4F, o-F) ppm. MS/EI (m/z): 664.2 (100%) [M+], 649.2 (35%) [M+ –CH3], 
620.2 (20%) [M+ -CH2CH3, -CH3]. HRMS-EI (C32H22B2F8N6): calcd.: 664.19588; found: 
664.19727. 
 
1,3-Diethyl-2-(5´-trimethylsilyl-thien-2´-yl)-1,3,2-benzodiazaborole (19) 
A solution of 2-trimethylsilylthiophene (2.1 g, 13.4 mmol) in diethyl ether (50 mL) was 
treated at room temperature with an n-hexane solution of n-butyllithium (1.6 M, 8.4 mL, 
13.4 mmol). After 1 h of stirring a sample of 2-bromo-1,3-diethyl-1,3,2-benzodiazaborole 
(3.38 g, 13.4 mmol) was added, and stirring was continued over night. Solvent was removed 
in vacuo, and the residue was distilled (bath temperature 180°C, 10-6 bar) to yield 3.57 g 
(10.9 mmol, 81%) of product 19. 1H NMR (C6D6): δ= 0.32 (s, 9H, SiMe3), 1.14 (t, 3JH,H 
=7.0 Hz, 6H, NCH2CH3), 3.73 (q, 3JH,H=7.0 Hz, 4H, NCH2CH3), 6.99 (m, 2H, 
CH=CHCH=CH), 7.13 (m, 2H, CH=CHCH=CH), 7.40 (d, 3JH,H=3.2 Hz, 1H, thiophene-H), 
7.51(d, 3JH,H=3.2 Hz, 1H, thiophene-H) ppm. 13C-{1H}-NMR (C6D6): δ= 0.00 (s, Si(CH3)3), 
16.1 (s, CH3CH2N), 37.8 (s, CH3CH2N), 109.2 (s, CH=CHCH=CH), 119.3 (s, 
CH=CHCH=CH), 135.1 (s, N2C2), 135.6, 137.5 (2s, thiophene-CH) 144.9 (s, thiophen-C-
Si) ppm. 11B-{1H}-NMR (C6D6): δ= 26.7 (s) ppm. MS/EI (m/z): 328.2 (100 %) [M+], 313.1 
(15%) [M+ –CH3].C17H25BN2SSi (328.36): calcd.: C: 62.18, H: 7.67, N: 8.53; found: C: 
61.86, H: 7.71, N: 8.47. 
 
2-(1´,3´-Bis(pentafluorophenyl)-1,3,2-benzodiazaborolyl)-5-(1´´,3´´-diethyl-1´´,3´´,2´´-
benzodiazaborolyl)-thiophene (13) 
The solution of 19 (0.656 g, 2.0 mmol) in CH2Cl2 (30 mL) was reacted at 20°C with boron 
tribromide (0.501 g, 2.0 mmol). After 1 h the solution of 0.577 g (2.2 mmol) of PPh3 in 
CH2Cl2 (10 mL) was added. After 2 h of stirring the mixture was liberated from solvents, and 
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NMR spectra were taken from the residue (δ11B (C6D6) = -5.9 (s), δ31P (C6D6) = -4.2 (s) 
ppm). The adduct was combined with N,N´-bis(pentafluorophenyl)phenylenediamine 15 
(0.792 g, 1.8 mmol) and 2,2,6,6-tetramethylpiperidine (0.636 g, 4.5 mmol) in toluene (70 mL) 
and the mixture was heated for 16 h at 100°C. After cooling to 20°C and filtration, the filtrate 
was evaporated to dryness. Triphenylphosphine was separated by sublimation at 90°C (10-
6 bar) before the residue was crystallised from n-hexane. The product 13 was obtained as 
colourless crystals (yield 0.580 g, 0.82 mmol, 46%). 1H NMR (C6D6): δ= 1.01 (t, 3JH,H 
=7.2 Hz, 6H, NCH2CH3), 3.49 (q, 3JH,H=7.1 Hz, 4H, NCH2CH3), 6.69 (m, 2H, 
CH=CHCH=CH-BN2(C6F5)2), 6.89 (m, 2H, CH=CHCH=CH-BN2Et2), 7.07 (m, 4H, 
CH=CHCH=CH-BN2(C6F5)2 and -BN2Et2), 7.24 (s, 2H, thiophene-H) ppm. 13C{1H} NMR 
(C6D6): δ= 15.7 (s, CH3CH2N), 37.6 (s, CH3CH2N), 109.1 (s, CH=CHCH=CHBN2Et2), 110.4 
(s, CH=CHCH=CH-BN2(C6F5)2), 119.3 (s, CH=CHCH=CHBN2Et2), 122.1 (s, 
CH=CHCH=CH-BN2(C6F5)2), 134.8, 137.0 (2s, thiophene-CH), 136.0, 136.2 (2s, N2C2), 
137.7 (dm, 1JC,F=255 Hz, C6F5), 140.9 (dm, 1JC,F=256 Hz, C6F5), 144.8 (dm, 1JC,F=255 Hz, 
C6F5) ppm. 11B{1H} NMR (C6D6): δ= 26.6 (s) ppm. 19F{1H} NMR (C6D6): δ= -161.1 (m, 4F, 
m-F) , -154.1 (t, 1JF,F=22 Hz, 2F, p-F), -145.1 (m, 4F, o-F) ppm. MS/EI (m/z): 704.1 (100%) 
[M+], 689.1 (43%) [M+ -Me]. C32H20B2F10N4S (704.20): calcd.: C: 54.58, H: 2.86, N: 7.96; 
found: C: 54.32, H: 3.06, N: 7.75. 
 
2-(1´,3´-Bis(2´,3´,5´,6´-tetrafluoropyridyl)-1,3,2-benzodiazaborolyl)-5-(1´´,3´´-diethyl-
1´´,3´´,2´´-benzodiazaborolyl)-thiophene (14) 
The dibromoboryl-triphenylphosphine adduct (1.445 g, 2.1 mmol) obtained by the 
reaction of 19 (0.656 g, 2.0 mmol) with BBr3 (0.501 g, 2.0 mmol) and the addition of PPh3 
(0.577 g, 2.2 mmol) analogue to protocol for 13, was reacted with ortho-phenylenediamine 16 
(0.731 g, 1.8 mmol) and 2,2,6,6-tetramethylpiperidine (0.636 g, 4.5 mmol) in toluene (70 mL) 
at 100°C for 30 h. After filtration, the filtrate was evaporated to dryness, and the residue was 
stirred in n-hexane (40 mL) and then filtered again. The filtrate was discarded, and the 
filtercake was washed with 10 mL of pentafluorobutane. The product 14 was isolated as 
yellow solid (0.250 g, 0.37 mmol, 21%). 1H NMR (C6D6): δ= 1.01 (t, 3JH,H =7.1 Hz, 6H, 
NCH2CH3), 3.46 (q, 3JH,H=7.1 Hz, 4H, NCH2CH3), 6.49 (m, 2H, CH=CHCH=CH-
BN2(C5F4N)2), 6.88 (m, 2H, CH=CHCH=CH-BN2Et2), 6.98 (m, 2H, CH=CHCH=CH-
BN2(C5F4N)2), 7.10 (m, 2H, CH=CHCH=CH-BN2Et2), 7.14 (s, 2H, thiophene-H) ppm. 
13C{1H} NMR (C6D6): δ= 15.9 (s, CH3CH2N), 37.5 (s, CH3CH2N), 109.1 (s, 
CH=CHCH=CHBN2Et2), 110.9 (s, CH=CHCH=CH-BN2(C5F4N)2), 119.4 (s, 
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CH=CHCH=CHBN2Et2), 122.8 (s, CH=CHCH=CH-BN2(C5F4N)2), 134.6, 135.0 (2s, 
thiophene-CH), 136.2, 136.9 (2s, N2C2), 138.9 (dm, 1JC,F=265 Hz, C5F4N), 144.0 (dm, 
1
JC,F=246 Hz, C5F4N) ppm. 11B{1H} NMR (C6D6): δ= 26.2 (s) ppm. 19F{1H} NMR (C6D6): 
δ= -144.7 (m, 4F, o-F), -87.7 (m, 4F, m-F) ppm. MS/EI (m/z): 670.1 (100%) [M+], 655.1 
(43%) [M+ -Me]. HRMS-EI (C30H20B2F8N6S): calcd.: 670.15230; found: 670.15298. 
 
1,2,3-Triphenyl-1,3,2-benzodiazaborole (20) 
Two separate solutions of N,N´-diphenyl-ortho-phenylenediamine (1.20 g, 4.6 mmol) and 
phenyldibromoborane (1.14 g, 4.6 mmol), each in 15 mL of toluene, were added dropwise 
to a well stirred slurry of CaH2 (1.00 g, 23.8 mmol) in 30 mL of cold toluene (0°C). After 
0.5 h of stirring at 0°C the slurry continued at room temperature for another 24 h. It was 
filtered and the flitrate was liberated from solvent. Recrystallisation of the residue afforded 
20 (1.27 g, 80%) as light yellow crystals. 1H NMR (CDCl3): δ=7.03 (m, 2H, 
CH=CHCH=CH), 7.10 (m, 4H, CH=CHCH=CH and 2-H-Ph), 7.14 (d, 3JH,H = 6.6 Hz, 2H, 2-
H-BPh), 7.21 (t, 3JH,H = 7.2 Hz, 1H, p-H-BPh), 7.33 (m, 6H, H-NPh), 7.42 (t, 3JH,H = 7.5 Hz, 
4H, H-NPh) ppm. 13C{1H} NMR (CDCl3): δ= 110.0 (s, CH=CHCH=CH), 120.0 (s, 
CH=CHCH=CH), 126.3 (3s, C-BPh), 127.3 (s, C-NPh), 127.8 (s, C-NPh), 128.6 (s, p-
C-BPh), 129.3 (s, C-NPh), 134.4 (s, C-BPh), 137.8(s, C-NPh), 140.4 (s, N2C2) ppm. 
11B{1H} NMR (C6D6): δ= 28.3 (s) ppm. MS/EI (m/z): 346.2 [M+], 268.1 [M+ -Ph-
H].C24H19BN2 (346.23): calcd.: C: 83.3, H: 5.5, N: 8.1; found: C: 82.3, H: 5.5, N: 7.6. 
 
Photophysical measurements 
For all solution state measurements, samples were placed in quartz cuvettes of 10 × 10 mm 
(Hellma type 111-QS, suprasil, optical precision). Cyclohexane was used as received from 
commercial sources (p. a. quality), the other solvents were dried by standard methods prior to 
use. Concentrations varied from 20 to 70 µM according to their optical density. Absorption 
was measured with a UV/VIS double-beam spectrometer (Shimadzu UV-2550), using the 
solvent as a reference. 
The output of a continuous Xe-lamp (75 W, LOT Oriel) was wavelength-separated by a first 
monochromator (Spectra Pro ARC-175, 1800 l/mm grating, Blaze 250 nm) and then used to 
irradiate a sample. The fluorescence was collected by mirror optics at right angles and imaged 
on the entrance slit of a second spectrometer while compensating astigmatism at the same 
time. The signal was detected by a back-thinned CCD camera (RoperScientific, 1024 \ 256 
pixels) in the exit plane of the spectrometer. The resulting images were spatially and 
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spectrally resolved. As the next step, an averaged fluorescence spectrum was calculated from 
the raw images and stored in the computer. This process was repeated for different excitation 
wavelengths. The result is a two-dimensional fluorescence pattern with the y-axis 
corresponding to the excitation, and the x-axis to the emission wavelength. The wavelength 
range is λex = 230-430 nm (in 1 nm increments) for the UV light and λem = 305-894 nm for 
the detector. The time to acquire a complete EES is typically less than 15 min. Post-
processing of the EES includes subtraction of the dark current background, conversion of 
pixel to wavelength scales, and multiplication with a reference file to take the varying lamp 
intensity as well as grating and detection efficiency into account. The quantum yields were 
determined against POPOP (p-bis-5-phenyl-oxazolyl(2)-benzene) (ΦF = 0.93) as the standard. 
The Lippert-Mataga studies on 11-14 are described in detail on pages S3-S5.  
Fluorescence lifetimes were measured with a time correlated single photon 
counting experiment. Pulses (3 ps) from a Ti:sapphire laser (Spektra Physics, 
Tsunami) were frequency tripled to get pulses with a wavelength of 297 nm. The 
resulting laser beam was used to excite the sample and the fluorescence was 
detected in the right angle with a MCP-PMT (Hamamatsu). The time dependence of 
the fluorescence photons was analysed with a picosecond-time-analyzer (PTA, 
Ortec), one discriminator creates the start signal from the detected fluorescence 
photons and the other creates the stop signal from the laser signal on a photodiode 
(Hamamatsu).  The resulting decay curves were deconvoluted with the laser puls 
signal and then a monoexponential fit was used to determine the fluorescence 
lifetime. 
 
 
Crystallographic data 
Crystallographic data were collected at 100 K. Crystallographic programmes used for 
structure solution and refinement were from SHELX-97.33 CCDC 961427-961429, and 
924348 contains the supplementary crystallographic data for this paper. These data can be 
obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
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 8 11 12 13 
Measurment device Nonius KappaCCD Bruker AXS X8 Prospector Ultra with APEX II Bruker KAPPA APEX II Bruker KAPPA APEX II 
λ [Å] 0.71073 1.54178 0.71073 0.71073 
Empirical formula C22 H7 B F10 N2 S C34 H22 B2 F10 N4 C32 H22 B2 F8 N6 C32 H20 B2 F10 N4 S 
Mr [g mol
-1] 532.17 698.18 664.18 704.20 
Crystal dimensions[mm] 0.22 x 0.19 x 0.12 0.30 x 0.26 x 0.11 0.24 x 0.17 x 0.14 0.29 x 0.21 x 0.13 
Crystal system Orthorhombic Triclinic Monoclinic Triclinic 
Space group P 212121 P 1 P21 P 1 
a[Ǻ] 11.234(2) 8.6356(3) 8.4303(6) 13.5530(8) 
b[Ǻ] 15.755(9) 12.0927(5) 20.4508(14) 15.9823(10) 
c[Ǻ] 22.977(7) 15.2734(5) 17.5857(12) 16.9069(10) 
α[°] 90 102.8230(17) 90 106.763(3) 
β[°] 90 91.6271(13) 94.393(4) 106.383(3) 
γ[°] 90 93.3910(15) 90 107.713(3) 
V[Ǻ3] 4067(3) 1551.05(10) 3023.0(4) 3053.5(3) 
Z  8 2 4 4 
ρcalc [g cm
-3] 1.738 1.495 1.459 1.532 
µ [mm-1] 0.266 1.138 0.122 0.199 
F (000) 2112 708 1352 1424 
Θ[°] 2-25 2.97-67.00 2.62-30.00 2.68-27.50 
No. refl. collected 32223 14335 103885 121751 
No. refl. unique 6853 11776 17618 14001 
R (int) 0.0686 0.0000 0.0360 0.0318 
No. refl. [I > 2σ(I)] 5310 11033 15046 11528 
Refined parameter 635 540 869 887 
GOF 1.103 1.048 1.011 1.017 
RF [I > 2 σ (I)] 0.0745 0.0344 0.0384 0.0335 
w RF2 (all data) 0.1753 0.0989 0.0974 0.0882 
∆ρmax/min [e Ǻ
-3] 0.620/-0.376 0.261/-0.232 0.349/-0.247 0.381/-0.307 
Remarks Disorder of both thiophene rings on two  
positions (55:45, 56:44). They were 
restrained to be same and refined 
isotropically, all other non-hydrogen atoms 
were refined anisotropically. 
meroedric twin 
 
twinned crystal, BASF   0.45135, reflections of 
both domains were used (HKLF 5) Rotated 
from first domain by 2.5 degrees about 
reciprocal axis -0.055  1.000  0.130 and real 
axis 0.002  1.000 0.249 Hydrogens were refined 
isotropically. 
 
  
CCDC-No. 961427 961428 961429 924348 
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Computational data 
 
All computations were carried out with the Gaussian 09 package.34 The S0 model geometries 
were fully optimised with the B3LYP functional35 with no symmetry constraints using the 6-
31G* basis set36 for all atoms. Frequency calculations on these optimised geometries (5 – 14, 
20) revealed no imaginary frequencies. Computed absorption data were obtained from TD-
DFT37 calculations on S0 geometries whereas computed TD-DFT emission data were from the 
fully optimised S1 geometries using the CAM-B3LYP functional.38 As the CAM-B3LYP 
functional generally overestimates the transition energies, compared to that of experimental 
and B3LYP data, a scaling factor of 0.85 was applied. The two distinct excited states LCT 
and RCT were located from different starting geometries using TD-DFT 
optimisations. Both states are defined computationally as S1 states even though they 
are different in energies. The MO diagrams were generated with the Gabedit package39 and 
the %MO contributions were obtained using the GaussSum software.40  
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